Genome-wide mapping indicates that p73 and p63 Co-occupy target sites and have similar DNA-binding profiles in vivo

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Yang, Annie ^a   Zhu, Zhou ^a   Kettenbach, Arminja ^a   Kapranov, Philipp ^b   McKeon, Frank ^a   Gingeras, Thomas R ^b   Struhl, Kevin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P63; PROTEIN P73; DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; BINDING SITE; CARCINOMA CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; UTERINE CERVIX CARCINOMA; CELL LINE; GENETIC ASSOCIATION; GENETICS; HUMAN GENOME; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BINDING;

BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA; DNA-BINDING PROTEINS; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 77955351317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011572     Document Type: Article

References (34)

1. Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90-95.
2. Belyi VA, Levine AJ (2009) One billion years of p53/p63/p73 evolution. Proc Natl Acad Sci U.S.A 106: 17609-17610.
3. Friedman PN, Chen X, Bargonetti J, Prives C (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U.S.A 90: 3319-3323.
4. Jeffrey PD, Gorina S, Pavletich NP (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502.
5. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, et al. (2006) Structural basis of DNA recognition by p53 tetramers. Mol Cell 22: 741-753.
6. Tidow H, Melero R, Mylonas E, Freund SM, Grossmann JG, et al. (2007) Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci U.S.A 104: 12324-12329.
7. Coutandin D, Lohr F, Niesen FH, Ikeya T, Weber TA, et al. (2009) Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ 16: 1582-1589.
8. Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV, et al. (2009) Structural evolution of p53, p63, and p73: Implication for heterotetramer formation. Proc Natl Acad Sci U.S.A 106: 17705-17710.
9. Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, et al. (2003) Positive and negative regulation of δN-p63 promoter activity by p53 and δN p63-alpha contributes to differential regulation of p53 target genes. Oncogene 22: 7607-7616.
10. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73 dependent apoptosis. Cancer Cell 9: 45-56.
11. Li N, Li H, Cherukuri P, Farzan S, Harmes DC, et al. (2006) TA-p63-gamma regulates expression of δN-p63 in a manner that is sensitive to p53. Oncogene 25: 2349-2359.
12. De Laurenzi V, Rossi A, Terrinoni A, Barcaroli D, Levrero M, et al. (2000) p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Comm 273: 342-346.
13. Lin YL, Sengupta S, Gurdziel K, Bell GW, Jacks T, et al. (2009) p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet 5: e1000680.
14. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713.
15. van Bokhoven H, McKeon F (2002) Mutations in the p53 homolog p63: allelespecific developmental syndromes in humans. Trends Mol Med 8: 133-139.
16. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718.
17. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, et al. (2006) p63 protects the female germ line during meiotic arrest. Nature 444: 624-628.
18. Kommagani R, Whitlatch A, Leonard MK, Kadakia MP (2010) p73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death Differ 17: 398-407.
19. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, et al. (2000) p73- deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103.
20. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, et al. (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 22: 2677-2691.
21. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ (2007) Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 21: 1882-1894.
22. Nelson EA, Walker SR, Alvarez JV, Frank DA (2004) Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem 279: 54724-54730.
23. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, et al. (2007) A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17: 1550-1561.
24. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, et al. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24: 593-602.
25. Geisberg JV, Struhl K (2004) Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucl Acids Res 32: e151.
26. Bailey TL, Elkan C (1995) The value of prior knowledge in discovering motifs with MEME. Proc Int Conf Intell Syst Mol Biol 3: 21-29.
27. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, et al. (2004) Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 14: 708-715.
28. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73 dependent apoptosis. Cancer Cell 9: 45-56.
29. Li W, Liu XS, Struhl K, Wade JT (2010) Distinguishing functional protein-DNA interactions from biological noise in genome-wide binding profiles. submitted.
30. Tanay A (2006) Extensive low-affinity transcriptional interactions in the yeast genome. Genome Res 16: 962-972.
31. Rocco JW, Ellisen LW (2006) p63 and p73: life and death in squamous cell carcinoma. Cell Cycle 5: 936-940.
32. DeYoung MP, Johannessen CM, Leong CO, Faquin W, Rocco JW, et al. (2006) Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res 66: 9362-9368.
33. DeYoung MP, Ellisen LW (2007) p63 and p73 in human cancer: defining the network. Oncogene 26: 5169-5183.
34. Hughes JD, Estep PW, Tavazoie S, Church GM (2000) Computational identification of cis-regulatory elements associated with groups of functionally related genes in Saccharomyces cerevisiae. J Mol Biol 296: 1205-1214.